ReviewInternational immunopharmacology2022

Roles of Interleukin-6-mediated immunometabolic reprogramming in COVID-19 and other viral infection-associated diseases.

Ying-Shuang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.